Sign in

or Register now

MyRACentral.com

    See all of our health sites at www.HealthCentral.com
    Friday, November 13, 2009
    • Font size
    • Bookmark
    • Save
    Receive a FREE Osteoarthritis of the knee pamphlet.  Start here.

    Drugmaker halts development of new RA drug

    (Reuters) UPDATED 2008-10-09
    Drugmaker Biogen has announced that it is halting development of a new rheumatoid arthritis (RA) medication. The drug, baminercept, failed to show that it was effective at treating RA in a mid-stage clinical trial. Biogen officials say they will continue to study the data on the drug and will present it at an upcoming scientific meeting.  Read full story >
    See all Rheumatoid Arthritis News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist